Carmel Egan, PhD, is the Associate Dean of Research Affairs at the Indiana University School of Medicine (IUSM), the Operations Director of Indiana University’s Precision Health Initiative, and the Chief Operating Officer for the Indiana Clinical and Translational Sciences Institute (CTSI).
Prior to joining IUSM in 2016, Dr. Egan was most recently the Vice President, Medicines Development Unit at Lilly, and has held a series of senior leadership positions at Lilly. She has served as Vice President of special Alzheimer’s disease initiatives in Lilly’s Biomedicines Business Unit and previously as Vice President of the Portfolio and Project Management group within Lilly Research Laboratories.
The Precision Health Initiative, funded in part by the IU Grand Challenges Initiative, is a $120 million multi-campus effort to incorporate the genetic, developmental, behavioral and environmental factors that contribute to an individual’s health and develop highly targeted therapies that will improve the well-being of both individuals and the community.
Dr. Egan, received her PhD in chemistry from the University College Dublin in Ireland prior to joining Lilly. She is married to Gerard Carthy and has two sons Gerard and Kevin.